Clinical Trial Update: A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the pharmacokinetic interaction between vemurafenib and acenocoumarol in BRAFV600 mutation-positive metastatic cancer patients and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Acenocoumarol (Acenocoumarol)
• Vemurafenib (Zelboraf) (vemurafenib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma, Neoplasms | Phase 1 | Status: COMPLETED